Jean de Pracomtal
Investment Banking
PARIS, 1 OCTOBER 2024 – Bryan, Garnier & Co, the leading investment bank for healthcare and technology-related companies, today announces that Jean de Pracomtal has been appointed as a Director, Equity Capital Markets (ECM). Jean, who is rejoining Bryan, Garnier & Co from Barclays, will help further drive the firm’s pan-European ECM franchise and help contribute to its ambitions of being the leader in capital formation for European growth companies.
Jean has over 10 years’ experience in ECM, five of which were spent at Barclays as a Director in the ECM team, working from origination to full execution on over 100 ECM transactions throughout EMEA, covering IPOs, rights issues, primary and secondary ABBs, converts and private placements across various sectors.
Before his time at Barclays, Jean spent five years, from Analyst to VP, at Bryan Garnier & Co, where he was also in charge of origination and execution of ECM deals mainly in the Biotech/Medtech space, helping to structure and execute a number of the firm’s ECM and private placement transactions.
He holds a degree in Law from Paris University and an Msc in Management from EM Lyon (Corporate Finance). Jean also spent six months in the French Land Army in Saint Cyr Military School.
Pierre Kiecolt-Wahl and Christophe Alleman, Co-Heads of Capital Markets stated: “We are very pleased to welcome back Jean de Pracomtal to Bryan, Garnier & Co as a Director in our Equity Capital Markets franchise. Jean brings a long and established track record of ECM successes in the EMEA market, which will significantly enhance the capital raising capabilities that we are able to offer to our clients across Europe and the UK.”
Jean de Pracomtal, Director, Equity Capital Markets said: “I am delighted to return to Bryan Garnier and be part of a dynamic and growing team focusing on executing challenging and complex transactions with our European growth company clients, their founders, and their investors. Bryan, Garnier has an outstanding track record in ECM, and I look forward to contributing to the team and our partners across the firm, including our sector, research, and distribution teams.”
With offices in Europe and the US, Bryan, Garnier & Co has established itself as one of the most active investment banks in pan-European growth financing via the public and private markets.
Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle. As a sector-focused bank since inception, Bryan Garnier specialises in Healthcare, Software & Fintech, Energy Transition and Sustainability, Industrial Tech, Business and Tech-Enabled Services and NextGen Consumer. Bryan Garnier’s mission of investment banking for a better future continues to drive the firm as it backs innovative companies and their investors that are providing solutions to some of the world’s most important challenges.
About Bryan, Garnier & Co
Bryan, Garnier’s is a European growth investment bank helping companies in the healthcare and technology related sectors become global champions. By combining deep sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and leading access to buyers and capital in Europe, US and Asia
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan, Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.